Arcturus Therapeutics Holdings Inc. Common Stock (ARCT)

Health Care·equity
$13.74
+6.76% today
Extended hours $13.55
Prices delayed about 15 minutes · cached page, can be an hour old or more
Market Census Score
60/ 100
Score level
Above average
5 of 6 checks had data

Price trend score is above the middle.

ARCT scores higher than 85% of the 1,101 tickers we compare it with (Health Care).

As of 9 October 2026, Arcturus Therapeutics Holdings Inc. Common Stock (ARCT) scores 60 out of 100 on the Market Census six-factor composite, which puts it at the Above average score level. The score is made from six named factors: price trend, strength vs the market, company finances, insider trades, market mood and recent momentum. It records what they read on 9 October 2026, and it is not investment advice.

Updated · scores usually change about once a day

Insider trades: no reading heldTrendStrengthFinancialsInsidersInsider trades: no reading heldMarketMomentum60/ 100

Key statistics

Market fields as reported. An em-dash means we hold no value for this ticker — most of the universe has no daily price or volume read.

Relative volume
0.75× 30-day average
52-week range
5.50 – 24.17
Market cap
$455.62M
Earnings date
9 Nov 2026
Volume
675,627
Avg. volume (30d)
897,049
Open
13.18
Previous close
12.87
Day's range (regular session)
12.87 – 14.32

The last trade can be an extended-hours trade, so it can sit outside the regular-session range.

Shown without a peer ranking — we hold no percentile for these yet, so there is nothing here to locate them against.

Beta
2.58
P/E (TTM)
—
EPS (TTM)
-3.31

Score breakdown · six named factors

Price trend
80
Strength vs the market
66
Company finances
33
Insider trades
—
Market mood
50
Recent momentum
75

Each bar is one part of the score, from 0 to 100. Read what the score means.

What the score says about ARCT right now

Arcturus Therapeutics Holdings Inc. Common Stock (ARCT) currently scores 60/100 on the Market Census six-factor composite, at the Above average score level. ARCT is +6.76% on the day and +5.41% over five sessions as of the most recent tick. Above average sits a bit above the middle. The data for ARCT leans good, with some weak spots. ARCT's strongest factor is price trend at 80/100 — a strong read on which way the price has been going. The weakest factor is company finances at 33/100 — below average company numbers. A low company-finances reading is the canonical "value trap" warning: technical setups on broken fundamentals don't tend to compound.

Generated from the six-factor breakdown above. Changes when the underlying scores do, usually about once a day. More on what the score means.

See ARCT in the scanner

This page is free to read with no account at all. Signing up takes an email and a password: a free account runs the scanner on the top 10 scored rows of any scan, keeps one saved screen, a 5-ticker watchlist, and opens 12 ticker detail pages a day. The card is what starts a 30-day Premium trial — $0 that day, then $19.99/month from day 30, cancel online any time before then — and that is what turns on every matching row instead of the first 10, alerts, the 200-ticker watchlist and recent insider buys (SEC Form 4).

Recent ARCT news

Latest headlines that name Arcturus Therapeutics, one per story, sourced from Market Census’s news feed (Polygon/Massive + Finnhub).

We hide 4 more that told readers to buy or sell, or gave a price target.

Saved snapshot; the news and prices on this page can be an hour old or more.

Similar setups in Health Care right now

Six health care tickers whose composite scores are closest to ARCT’s 60, all within 1 point.

Sorted by closeness to ARCT’s composite score within Health Care. Saved snapshot; can be an hour old or more. Run the full scanner →

Prices delayed about 15 minutes; scores usually change about once a day. Not investment advice — see risk disclosure.